Lab news
FOCIS 2022
Poster of Distinction Awards
Puchong Thirawatananond
Selective CD226 Knockout on Regulatory T cells Reduces Diabetes in Female NOD Mice
Matt Brown
Human CD4+CD25+Regulatory T Cells Deficient of CD226 Demonstrate Increased Purity and Lineage Stability Following Ex Vivo Expansion for Adoptive Treg Therapy
FOCIS 2022
Oral Presentations
Melanie Shapiro
Autoimmunity Risk Loci Tagged to CIITA and MHC Class II Impact CD8+ T Cell and Monocyte HLA-DR Expression
Matt Brown
Human CD4+CD25+Regulatory T Cells Deficient of CD226 Demonstrate Increased Purity and Lineage Stability Following Ex Vivo Expansion for Adoptive Treg Therapy
FOCIS 2022 Poster Presentations
Leeana Peters
Engineering Optimized Autoreactive T cells for the Study of Type 1 Diabetes Pathogenesis
Miguel Medina-Serpas
Integrating spatial transcriptomics and single-cell RNA sequencing to spatially characterize human lymphatic tissue
2022 Graduates with Honor Thesis
Lindsey Sachs
Matt Brown
Juan Martin Arnoletti
New “Pancreatic Islet on a Chip” System Will…
University of Florida researchers will use a new $5 million grant to develop a “pancreatic islet on a chip” — a platform that will allow them…
Human Atlas of Neonatal Development and Early…
Human Atlas of Neonatal Development and Early Life-Immunity (HANDEL-I) The early life events that influence immune system development have…
Helmsley Grant to UFDI to Study Immune Repertoire…
University of Florida and Kings College London have secured a $3.7 million grant funded by Adaptive Biotechnologies and the Leona M. and Harry B…
T1D news
June 27, 2022
‘Transformational’ cell-based therapy ‘effective’ in helping those with hard-to-control type 1 diabetes
October 20, 2021
A new therapy for treating Type 1 diabetes
August 29, 2019
Pancreas on a chip – Beta Cell Transplantation
September 20, 2021
TechnologyNetworks Diagnostics
International Clinical Centers
Type 1 Diabetes TrialNet
The University of Florida (UF) is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Desmond Schatz, MD, the TrialNet team at UF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.
